The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Body mass index (BMI) as prognostic in metastatic colorectal cancer (mCRC): A pooled analysis of 21 first-line trials in the ARCAD database.
Lindsay A. Renfro
No relevant relationships to disclose
Fotios Loupakis
No relevant relationships to disclose
Richard A. Adams
No relevant relationships to disclose
Matthew T. Seymour
No relevant relationships to disclose
Hans-Joachim Schmoll
No relevant relationships to disclose
Jean-Yves Douillard
No relevant relationships to disclose
Herbert Hurwitz
No relevant relationships to disclose
Charles S. Fuchs
No relevant relationships to disclose
Eduardo Diaz-Rubio
No relevant relationships to disclose
Rainer Porschen
No relevant relationships to disclose
Christophe Tournigand
No relevant relationships to disclose
Alfredo Falcone
No relevant relationships to disclose
Niall C. Tebbutt
No relevant relationships to disclose
J. Randolph Hecht
No relevant relationships to disclose
Cornelis J. A. Punt
No relevant relationships to disclose
Richard M. Goldberg
No relevant relationships to disclose
Leonard Saltz
No relevant relationships to disclose
Aimery De Gramont
No relevant relationships to disclose
Daniel J. Sargent
No relevant relationships to disclose
Heinz-Josef Lenz
No relevant relationships to disclose